Data at 2026 Boswick Burn & Wound Symposium highlight first integrated use of AVITA Medical technologies [Yahoo! Finance]
Avita Medical, Inc. (RCEL)
Company Research
Source: Yahoo! Finance
New clinical and tissue-level data on PermeaDerm and Cohealyx highlight wound bed preparation and readiness for closure RECELL analyses show consistent trends in healing, reduced complications, and shorter hospital stays across studies and real-world registry data VALENCIA, Calif., Jan. 25, 2026 (GLOBE NEWSWIRE) -- AVITA Medical®, Inc. (ASX: AVH, NASDAQ: RCEL), a leading therapeutic acute wound care company delivering transformative solutions, today announced data from 19 scientific abstracts, including 14 podium presentations, at the 2026 Boswick Burn & Wound Symposium. The presentations include the first surgeon-reported integrated use of all three AVITA Medical technologies – RECELL, PermeaDerm, and Cohealyx – in individual patient cases, as well as clinical and tissue-level findings from separate studies evaluating PermeaDerm and Cohealyx. Additional presentations at the meeting build on AVITA Medical's established RECELL evidence base, offering synthesis and real-world ins
Show less
Read more
Impact Snapshot
Event Time:
RCEL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RCEL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RCEL alerts
High impacting Avita Medical, Inc. news events
Weekly update
A roundup of the hottest topics
RCEL
News
- AVITA Medical, Inc.'s (NASDAQ:RCEL) Shift From Loss To Profit [Yahoo! Finance]Yahoo! Finance
- Avita Medical (NASDAQ:RCEL) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $10.00 price target on the stock.MarketBeat
- Data at 2026 Boswick Burn & Wound Symposium highlight first integrated use of AVITA Medical technologiesGlobeNewswire
- Avita Medical (NASDAQ:RCEL) had its "hold" rating reaffirmed by analysts at Lake Street Capital.MarketBeat
- Avita Medical (NASDAQ:RCEL) had its price target lowered by analysts at D. Boral Capital from $14.00 to $10.00. They now have a "buy" rating on the stock.MarketBeat
RCEL
Earnings
- 11/6/25 - Miss
RCEL
Sec Filings
- 1/30/26 - Form SCHEDULE
- 1/13/26 - Form 8-K
- 1/5/26 - Form 8-K
- RCEL's page on the SEC website